Sarah Silbiger/Getty Images(WASHINGTON) -- The Food and Drug Administration and Abbott Nutrition have agreed on a plan to resume operations at its infant formula facility in Sturgis, Michigan, the company announced on Monday. While the news will be welcomed by frustrated dealing who are struggling find formula on shelves, it still could be several more weeks before they see relief. According to Abbott, the agreement with the FDA lays out "the steps necessary to resume production and maintain the facility" but remains subject to court approval. Abbott said that once the FDA gives it t...